Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia-Reference-Cited by-同舟云学术

Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia

Published:2015-09-01 Issue:3 Volume:231 Page:680-687
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J. Cell. Physiol.

Author:

Ciarcia Roberto¹,Damiano Sara¹,Puzio Maria Valeria¹,Montagnaro Serena¹,Pagnini Francesco¹,Pacilio Carmen²,Caparrotti Giuseppe³,Bellan Cristiana⁴,Garofano Tiziana⁵,Polito Maria Sole⁴,Giordano Antonio⁴⁵⁶,Florio Salvatore¹

Affiliation:

1. Department of Veterinary Medicine and Animal Productions; University of Naples “Federico II”; Naples Italy

2. Clinical Trials Unit; Istituto Nazionale per lo Studio e la Cura dei Tumori; Fondazione G. Pascale-IRCCS; Naples Italy

3. Department of Haematology; ASL Caserta (CE); Hospital Moscati; Aversa (CE) Italy

4. Department of Medicine; Surgery and Neuroscience; University of Siena; Siena Italy

5. AORN Dei Colli Monaldi UOC; Oncology; Naples Italy

6. Sbarro Institute for Cancer Research and Molecular Medicine; Center of Biotechnology; College of Science and Technology; Temple University; Philadelphia Pennsylvania

Funder

Italian Asociation Leukaemia and Lymphoma (A.I.L.) - Caserta-ONLUS

Human Health Foundation - ONLUS

Sbarro Health Research Organization

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcp.25118/fullpdf

Reference43 articles.

1. Independent stimulation of motility and theoxidative metabolic burst of human polymorphonuclear leukocytes;Bass;J Immunol,1978